Concord Drugs share news and announcements
BSE: 538965Pharmaceuticals & BiotechnologySmall Cap
Last close ₹68.06down ₹0.94 (1.36%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹69.00.
52-week range of traded prices to 23 Oct 2026
₹61.00Low, 23 Oct 2025₹92.52High, 13 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹90 Cr3,001st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 10 Aug 2026
- 43.7
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 10 Aug 2026
- 5.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 10 Aug 2026
- 7.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 27 May 2026
- 0.28
- Volume, BSEVolume. Shares traded on the last trading day.
- 1,703
Concord Drugs routine notices
110 filed, newest first. Page 3 of 3.
Aug 2017
May 2017
Jan 2017
Nov 2016
Aug 2016
1 Aug · Routine
Trading window in respect of the Company’s Securities shall remain closed for all the Directors/Officers/Designed Employees of the Company from ....
May 2016
19 May · Routine
Trading window in respect of the Company's Securities shall remain closed for all the Directors/Officers/Designed Employees of the Company from ....
Feb 2016
2 Feb · Routine
Meeting of the Board of Directors of the Company will be held on February 13, 2016, inter alia, to consider the following: 1. Un-audited ....
Nov 2015
2 Nov · Routine
Meeting of the Board of Directors of the Company will be held on November 14, 2015, inter alia, to consider the following: 1. Unaudited ....
Jul 2015
29 Jul · Routine
As per the Company’s internal Code for Prevention of Insider Trading (as amended w.e.f. May 15, 2015) the trading window for dealing in the securities ....
May 2015
14 May · Routine
Meeting of the Board of Directors of the Company will be held on May 30, 2015, to consider the following: 1. Audited Financial Results for ....